Skip to main content
. 2017 Nov 8;7:15101. doi: 10.1038/s41598-017-15415-4

Figure 4.

Figure 4

Purified recombinant HAI-2 proteins repressed cellular matriptase activation and prostate cancer cell motility. (A,B) Effects of purified recombinant HAI-2 proteins on matriptase in N2 (A) and PC-3 cells (B). Cells were treated with the indicated concentrations of rHAI-2 (Cat.1106-PI-010, R&D system, MN, USA, which was produced from mouse myeloma cells) and incubated for 20 hours. The conditioned media and cells lysates were collected for immunoblotting analysis using anti-HAI-2 pAb, M32 and M69 mAbs to detect the levels of rHAI-2 in the conditioned media and matriptase (total and activated levels) in cells, respectively. β-actin was used as control. (C,D) Effects of purified recombinant HAI-2 (rHAI-2) proteins on N2 (C) and PC-3 (D) cell migration and invasion. Cells were seeded at a density of 2 × 105 (N2) or 5 × 104 (PC-3) cells per well of Boyden chambers and treated with the indicated concentrations of rHAI-2 proteins. Boyden chambers were coated with or without Matrigel before cell seeding for cell invasion and migration assays. Migration assays were performed for 24 hours (N2) and 16 hours (PC-3) and invasion assays were carried out for 48 hours (N2) and 24 hours (PC-3). The results of cell migration and invasion were statistically calculated from three independent experiments and represented as mean ± SD. (*p < 0.05; **p < 0.01, one-way ANOVA).